met

Documents about met

• Tepotinib in Solid Tumors Harboring MET Alterations#883167ClinicalTrials.gov
• Assessing the PK of Met DR, Met IR, and Met XR in Healthy Subjects#158170ClinicalTrials.gov
• Phase II of Neoadjuvant and Adjuvant Capmatinib in NSCLC#1165172ClinicalTrials.gov
• Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies#1381945ClinicalTrials.gov
• How We Met#1253572Open Library
• Well Met#1314093Open Library
• Management of adverse events associated with MET TKIs in patients with advanced NSCLC: A podcast discussion#684727Figshare
• Bozitinib Combined With Chemotherapy as Radical Treatment for Stage IIA-IIIC MET-Altered Non-Small Cell Lung Cancer#1246673ClinicalTrials.gov
• Middle-Ear Implant With MET V Transducer (Aka MET V System)#811123ClinicalTrials.gov
• Vebreltinib Plus Chemotherapy as First-line Treatment for MET-overexpressing NSCLC#1293882ClinicalTrials.gov
• Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)#1409298ClinicalTrials.gov
• RW Effectiveness of Capmatinib in Advanced MET-dysregulated NSCLC Included in the French Compassionate Use Program (ATU)#889546ClinicalTrials.gov
• Aristoteles, Met. XII – eine Theologie?#769512PhilArchive
• When Historiography Met Epistemology#771321PhilArchive
• Amivantamab in Participants With Advanced NSCLC and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS Study#14270HAL (France)
• Study of REGN5093-M114 (METxMET Antibody-Drug Conjugate) in Adult Patients With Mesenchymal Epithelial Transition Factor (MET) Overexpressing Advanced Cancer#917893ClinicalTrials.gov
• Study of GSK1363089 in Metastatic Gastric Cancer#1163799ClinicalTrials.gov
• Effects of MET-3 and MET-5 on Gut Microbiome and Metabolic Function in Men and Women With Hypertriglyceridemia#1211878ClinicalTrials.gov
• A Study of MET Concordance and Gene Profiling in 1L NSCLC (Genomet)#1378653ClinicalTrials.gov
• Study of ABT-700 in Subjects With Advanced Solid Tumors#1112766ClinicalTrials.gov
• Tepotinib Plus Paclitaxel in MET Amplified or MET Exon 14 Alterated Gastric and GEJ Carcinoma#828782ClinicalTrials.gov
• Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers#846669ClinicalTrials.gov
• A Study of Capmatinib (INC280) in NSCLC Patients With MET Exon 14 Alterations Who Have Received Prior MET Inhibitor#885761ClinicalTrials.gov
• A Pilot Study of Crizotinib in Patients With c-MET Positive Gastric Adenocarcinoma as a Third-line Chemotherapy#894900ClinicalTrials.gov
• Prioriteit voor patienten met een lagere levenskwaliteit#775995PhilArchive
• Kerstmis met Boer Boris / Boer Boris, Gottmer Kinderboeken#1386011Deutsche Nationalbibliothek
• Immunological effects of amivantamab in EGFR or MET-expressing non-small cell lung cancer#309401OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Prognostic Value and Clinical Pathology of c-MET Expression and Amplification in Gastric Carcinoma#1437746ClinicalTrials.gov
• APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors#1350927ClinicalTrials.gov
• A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer#1430357ClinicalTrials.gov
• Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors#1243394ClinicalTrials.gov
• Charles Ray and the Uncanny at the Met#107326PhilArchive
• DANHEART (H-HeFT and Met-HeFT)#387131ClinicalTrials.gov
• Friedrich Nietzsche's Flirt met Paradoxen en Chaos.#768741PhilArchive
• MEK and MET Inhibition in Colorectal Cancer#1125303ClinicalTrials.gov
• Echtgenote met zwarte man in swingersclub. 1 : Verboden erotische verhalen met expliciete seks voor volwassenen / Mia Graf#1145432Deutsche Nationalbibliothek
• CNS Dose Escalation/Expansion of Tepotinib in MET-driven NSCLC#1231274ClinicalTrials.gov
• To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation#1474950ClinicalTrials.gov
• Vebreltinib for Neoadjuvant in MET-altered Stage IIIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)#1172837ClinicalTrials.gov
• Office Refurbishment 2026 — MET OFFICE — FMS Interior Services LTD#656272UK Contracts Finder
• A Biomarker-implemented Clinical Study Evaluating Mutations in MET and TP53 in a Population of Treatment-refractory Squamous Cell Carcinoma#882996ClinicalTrials.gov
• HVAC project support services 2026 — MET OFFICE — Ward Williams Associates#1022155UK Contracts Finder
• When Moral Responsibility Theory Met My Philosophy of Disability#696859PhilArchive
• Possible Worlds in the Precipice: Why Leibniz Met Spinoza?#775571PhilArchive
• Validity of the MET-REPAIR Questionnaire#1487061ClinicalTrials.gov
• Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors#1112593ClinicalTrials.gov
• Getrouwd met mijn baas voor twaalf verboden fantasieën. 1 : Verboden erotische verhalen met expliciete seks voor volwassenen / Mia Graf#1202925Deutsche Nationalbibliothek
• Getrouwd met mijn baas voor twaalf verboden fantasieën. 1 : Verboden erotische verhalen met expliciete seks voor volwassenen / Mia Graf#1202932Deutsche Nationalbibliothek
• Study Efficacy and Safety of INC280 in Patients With Advanced Hepatocellular Carcinoma.#1320276ClinicalTrials.gov
• INtra-operative Evaluation of a Novel FLUorescENt C-mEt Tracer in Penile and Tongue#1349570ClinicalTrials.gov